UBS Group’s ProShares Ultra Health Care RXL Stock Holding History

UBS Group’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-161	Closed	-$8.34K	–	11073
2025 Q4	$8.34K	Sell	161 -11	-6%	-$537	﹤0.01%	8371
2025 Q3	$7.31K	Sell	172 -188	-52%	-$7.61K	﹤0.01%	8731
2025 Q2	$14.6K	Buy	+360	New	+$14.8K	﹤0.01%	8644
2025 Q1	–	Sell	-83	Closed	-$3.65K	–	10652
2024 Q4	$3.65K	Sell	83 -1,295	-94%	-$65K	﹤0.01%	8846
2024 Q3	$77.1K	Buy	1,378 +1,348	+4,493%	+$73.4K	﹤0.01%	6538
2024 Q2	$1.53K	Buy	+30	New	+$1.49K	﹤0.01%	8559
2024 Q1	–	Sell	-488	Closed	-$22.3K	–	9921
2023 Q4	$22.3K	Buy	+488	New	+$20.4K	﹤0.01%	7041
2022 Q4	–	Sell	-1,642	Closed	-$63K	–	11079
2022 Q3	$63K	Buy	1,642 +1,640	+82,000%	+$72.3K	﹤0.01%	6125
2022 Q2	$0	Buy	+2	New	+$92	﹤0.01%	10847

Other funds holding RXL

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

UBS Group's RXL Position: Q1 2026 in Review

UBS Group sold out of ProShares Ultra Health Care (RXL) in Q1 2026, closing a stake of 161 shares — an estimated $8.34K sold.

UBS Group first reported a position in RXL in Q2 2022 and held it in 9 quarters. The position peaked at $77.1K in Q3 2024. 17 funds tracked by Wall St. Rank hold RXL as of Q1 2026.

UBS Group reported no remaining ProShares Ultra Health Care position as of Q1 2026 after selling out during the quarter.
UBS Group sold 161 ProShares Ultra Health Care shares in Q1 2026, an estimated $8.34K.
UBS Group first reported a position in ProShares Ultra Health Care in Q2 2022 and held it in 9 quarters.
UBS Group's ProShares Ultra Health Care position peaked at $77.1K in Q3 2024.
17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.